echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > BMJ Sub-Journal: Loss of GPR21 improves glucose homeostasis and inhibits the CCL2-CCR2 axis through different mechanisms

    BMJ Sub-Journal: Loss of GPR21 improves glucose homeostasis and inhibits the CCL2-CCR2 axis through different mechanisms

    • Last Update: 2021-12-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Chronic low-grade inflammation is part of the pathogenesis of obesity-induced insulin resistance, manifested by immune cells infiltrating adipose tissue
    .


    The number of metabolic and immune cells (including fat cells and macrophages) parallels the activation of various pro-inflammatory receptors and signaling pathways, establishing a mechanical link between insulin resistance and inflammation


    Chronic low-grade inflammation is part of the pathogenesis of obesity-induced insulin resistance, manifested by immune cells infiltrating adipose tissue


    The potential role of the


    The results of the study showed that the high-fat feeding study of Gpr21 mice had improved glucose tolerance and slight changes in the expression of inflammatory genes
    .


    Gpr21−/− monocytes and peritoneal macrophages have impaired chemotaxis selectivity to monocyte chemoattractant protein (MCP)-1, although the expression of Ccr2 has not changed


    Into the genotype analysis further showed that chemotaxis damage due to monocyte polarization caused by imbalance


    After the 16-week feeding period, the wild-type control group fed a high-fat diet (HFD) showed an expected increase in body weight compared to animals fed a normal diet (NC) (Figure 2A, B, n=6-12)
    .


    Gpr21−/− Compared with the control mice, the animals taking HFD gained less weight, and during the whole experiment, whether they took HFD or NC, the weight gain was the same (Figure 2B, n=6-12)


    After the 16-week feeding period, the wild-type control group fed a high-fat diet (HFD) showed an expected increase in body weight compared to animals fed a normal diet (NC) (Figure 2A, B, n=6-12)


    Overall, human and mouse data indicate that GPR21 affects glucose homeostasis and MCP-1/CCL2-CCR2-driven monocyte migration


    References: RiddyDM ,KammounHL ,MurphyAJ RiddyDM Riddy KammounHL Kammoun MurphyAJ Murphy , et al.
    BMJ Open Diabetes Research and Care 2021; 9: e002285.
    doi:10.
    1136/bmjdrc-2021-002285 doi:  10.
    1136/bmjdrc -2021-002285 doi: leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.